• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.儿童慢性肾脏病(CKiD)队列中25-羟基维生素D缺乏症的患病率及其相关因素。
Pediatr Nephrol. 2016 Jan;31(1):121-9. doi: 10.1007/s00467-015-3190-7. Epub 2015 Aug 26.
2
Disordered FGF23 and mineral metabolism in children with CKD.慢性肾脏病儿童中紊乱的成纤维细胞生长因子 23 和矿物质代谢。
Clin J Am Soc Nephrol. 2014 Feb;9(2):344-53. doi: 10.2215/CJN.05840513. Epub 2013 Dec 5.
3
Vitamin D status of children with moderate to severe chronic Kidney Disease at a Tertiary Pediatric Center in Cape Town.开普敦一家三级儿科中心中重度慢性肾病患儿的维生素D状况
Saudi J Kidney Dis Transpl. 2019 Jul-Aug;30(4):781-794. doi: 10.4103/1319-2442.265453.
4
Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults.明显健康的叙利亚成年人中维生素D状态及甲状旁腺激素水平与骨密度的关系
Arch Osteoporos. 2016;11:18. doi: 10.1007/s11657-015-0245-0. Epub 2016 Apr 28.
5
Relationship between 25-hydroxyvitamin D concentrations, serum calcium, and parathyroid hormone in apparently healthy Syrian people.叙利亚健康人群中 25-羟维生素 D 浓度、血清钙和甲状旁腺激素之间的关系。
Arch Osteoporos. 2014;9:176. doi: 10.1007/s11657-014-0176-1. Epub 2014 Apr 9.
6
Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.肾功能和25-羟维生素D浓度可预测肾移植患者的甲状旁腺激素水平。
Nephrol Dial Transplant. 2006 Sep;21(9):2621-4. doi: 10.1093/ndt/gfl201. Epub 2006 Apr 27.
7
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.提高慢性肾脏病患者血清 25-羟维生素 D 现行临床实践指南靶目标的理由。
Am J Nephrol. 2019;49(4):284-293. doi: 10.1159/000499187. Epub 2019 Mar 15.
8
Posterior urethral valves: Metabolic consequences in a cohort of patients.后尿道瓣膜:一组患者的代谢后果
J Pediatr Urol. 2015 Aug;11(4):216.e1-6. doi: 10.1016/j.jpurol.2015.04.022. Epub 2015 Jun 4.
9
Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease.维生素 D 不足及胆钙化醇对慢性肾脏病儿童的影响。
Pediatr Nephrol. 2010 Dec;25(12):2483-8. doi: 10.1007/s00467-010-1639-2. Epub 2010 Sep 25.
10
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.成纤维细胞生长因子23与儿童慢性肾脏病进展风险
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1989-1998. doi: 10.2215/CJN.02110216. Epub 2016 Aug 25.

引用本文的文献

1
Vitamin D: What We Know and What We Still Do Not Know About Vitamin D in Preterm Infants-A Literature Review.维生素D:关于早产儿维生素D我们所知道的和仍然未知的——一篇文献综述
Children (Basel). 2025 Mar 20;12(3):392. doi: 10.3390/children12030392.
2
Vitamin D and its associations with blood pressure in the Chronic Kidney Disease in Children (CKiD) cohort.维生素 D 及其与慢性肾脏病儿童队列(CKiD)中血压的关系。
Pediatr Nephrol. 2024 Nov;39(11):3279-3288. doi: 10.1007/s00467-024-06434-1. Epub 2024 Jul 6.
3
Mineral Metabolism in Children: Interrelation between Vitamin D and FGF23.儿童矿物质代谢:维生素 D 与 FGF23 的相互关系。
Int J Mol Sci. 2023 Apr 3;24(7):6661. doi: 10.3390/ijms24076661.
4
The clinical relevance of native vitamin D in pediatric kidney disease.儿童肾脏病中内源性维生素 D 的临床相关性。
Pediatr Nephrol. 2023 Apr;38(4):945-955. doi: 10.1007/s00467-022-05698-9. Epub 2022 Aug 5.
5
Nutritional Assessment and Management in Paediatric Chronic Kidney Disease.小儿慢性肾脏病的营养评估与管理
J Nutr Metab. 2021 Oct 12;2021:8283471. doi: 10.1155/2021/8283471. eCollection 2021.
6
Factors associated with the absence of pharmacological treatment for common modifiable complications in children with chronic kidney disease.与慢性肾脏病儿童常见可修正并发症的药物治疗缺失相关的因素。
Pediatr Nephrol. 2021 Oct;36(10):3181-3189. doi: 10.1007/s00467-021-05087-8. Epub 2021 May 6.
7
Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease.种族和民族预测慢性肾脏病儿科患者的骨标志物和骨折。
J Bone Miner Res. 2021 Feb;36(2):298-304. doi: 10.1002/jbmr.4182. Epub 2020 Oct 23.
8
The CKiD study: overview and summary of findings related to kidney disease progression.CKiD 研究:肾脏病进展相关的研究概况和研究结果总结。
Pediatr Nephrol. 2021 Mar;36(3):527-538. doi: 10.1007/s00467-019-04458-6. Epub 2020 Feb 3.
9
Chronic Kidney Disease: Treatment of Comorbidities I: (Nutrition, Growth, Neurocognitive Function, and Mineral Bone Disease).慢性肾脏病:合并症的治疗I:(营养、生长、神经认知功能和矿物质骨病)
Curr Treat Options Pediatr. 2019 Jun 15;5:78-92. doi: 10.1007/s40746-019-00152-9. Epub 2019 Apr 15.
10
Bone Health in Glomerular Kidney Disease.肾小球肾病中的骨骼健康。
Curr Osteoporos Rep. 2019 Dec;17(6):570-579. doi: 10.1007/s11914-019-00531-z.

本文引用的文献

1
The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.维生素 D 状态对慢性肾脏病中成纤维细胞生长因子 23 和甲状旁腺激素相对增加的影响。
Kidney Int. 2014 Aug;86(2):407-13. doi: 10.1038/ki.2013.537. Epub 2014 Jan 15.
2
Disordered FGF23 and mineral metabolism in children with CKD.慢性肾脏病儿童中紊乱的成纤维细胞生长因子 23 和矿物质代谢。
Clin J Am Soc Nephrol. 2014 Feb;9(2):344-53. doi: 10.2215/CJN.05840513. Epub 2013 Dec 5.
3
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.黑人和白人的维生素 D 结合蛋白和维生素 D 状况。
N Engl J Med. 2013 Nov 21;369(21):1991-2000. doi: 10.1056/NEJMoa1306357.
4
Vitamin D, race, and risk for anemia in children.维生素 D、种族与儿童贫血风险。
J Pediatr. 2014 Jan;164(1):153-158.e1. doi: 10.1016/j.jpeds.2013.08.060. Epub 2013 Oct 8.
5
Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.儿童慢性肾脏病中的维生素 D 生物利用度和分解代谢。
Pediatr Nephrol. 2013 Sep;28(9):1843-53. doi: 10.1007/s00467-013-2493-9. Epub 2013 Jun 2.
6
Prevalence of vitamin D deficiency among overweight and obese US children.超重和肥胖美国儿童中维生素 D 缺乏症的流行率。
Pediatrics. 2013 Jan;131(1):e152-61. doi: 10.1542/peds.2012-1711. Epub 2012 Dec 24.
7
25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study.25-羟维生素 D 水平与 AusDiab(澳大利亚糖尿病、肥胖与生活方式)研究中的慢性肾脏病。
BMC Nephrol. 2012 Jul 3;13:55. doi: 10.1186/1471-2369-13-55.
8
Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C.应用免疫比浊法测定胱抑素 C 改良方程估算慢性肾脏病儿童的肾小球滤过率。
Kidney Int. 2012 Aug;82(4):445-53. doi: 10.1038/ki.2012.169.
9
Vitamin D status in children with chronic kidney disease.维生素 D 状态在慢性肾脏病患儿中的表现。
Pediatr Nephrol. 2012 Aug;27(8):1341-50. doi: 10.1007/s00467-012-2143-7. Epub 2012 Mar 28.
10
Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial.口服骨化三醇治疗儿童慢性肾脏病继发性甲状旁腺功能亢进随机试验
Clin J Am Soc Nephrol. 2012 Feb;7(2):216-23. doi: 10.2215/CJN.04760511. Epub 2012 Jan 19.

儿童慢性肾脏病(CKiD)队列中25-羟基维生素D缺乏症的患病率及其相关因素。

Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.

作者信息

Kumar Juhi, McDermott Kelly, Abraham Alison G, Friedman Lisa Aronson, Johnson Valerie L, Kaskel Frederick J, Furth Susan L, Warady Bradley A, Portale Anthony A, Melamed Michal L

机构信息

Department of Pediatrics, Weill Cornell Medical College, New York, NY, USA.

, 505 East 70th Street, Box 176, New York, NY, 10021, USA.

出版信息

Pediatr Nephrol. 2016 Jan;31(1):121-9. doi: 10.1007/s00467-015-3190-7. Epub 2015 Aug 26.

DOI:10.1007/s00467-015-3190-7
PMID:26307635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4884450/
Abstract

BACKGROUND

Vitamin D plays an important role in the mineral and bone disorder seen in chronic kidney disease (CKD). Deficiency of 25-hydroxyvitamin D (25OHD) is highly prevalent in the adult CKD population.

METHODS

The prevalence and determinants of 25OHD deficiency (defined as a level <20 ng/ml) were examined longitudinally in 506 children in the CKiD cohort. Predictors of secondary hyperparathyroidism and the determinants of 1,25-dihydroxyvitamin D (1,25(OH)2D) levels were also evaluated.

RESULTS

Deficiency of 25OHD was observed in 28 % of the cohort at enrollment. Significant predictors of 25OHD deficiency were older age, non-white race, higher body mass index, assessment during winter, less often than daily milk intake, non-use of nutritional vitamin D supplement and proteinuria. Lower values of glomerular filtration rate (GFR), serum 25OHD, calcium and higher levels of FGF23 were significant determinants of secondary hyperparathyroidism. Lower GFR, low serum 25OHD, nephrotic-range proteinuria, and high FGF23 levels were significant determinants of serum 1,25(OH)2 D levels.

CONCLUSIONS

Deficiency of 25OHD is prevalent in children with CKD and is associated with potentially modifiable risk factors such as milk intake, nutritional vitamin D supplement use, and proteinuria. 25OHD deficiency is a risk factor for secondary hyperparathyroidism and decreased serum 1,25(OH)2D in children with CKD.

摘要

背景

维生素D在慢性肾脏病(CKD)所见的矿物质和骨疾病中起重要作用。25-羟基维生素D(25OHD)缺乏在成年CKD人群中极为普遍。

方法

对CKiD队列中的506名儿童进行纵向研究,以检查25OHD缺乏(定义为水平<20 ng/ml)的患病率及其决定因素。还评估了继发性甲状旁腺功能亢进的预测因素和1,25-二羟基维生素D(1,25(OH)2D)水平的决定因素。

结果

入组时,该队列中有28%的儿童存在25OHD缺乏。25OHD缺乏的显著预测因素为年龄较大、非白种人、较高的体重指数、冬季评估、牛奶摄入频率低于每日一次、未使用营养性维生素D补充剂以及蛋白尿。较低的肾小球滤过率(GFR)、血清25OHD、钙水平以及较高的成纤维细胞生长因子23(FGF23)水平是继发性甲状旁腺功能亢进的显著决定因素。较低的GFR、低血清25OHD、肾病范围蛋白尿以及高FGF23水平是血清1,25(OH)2D水平的显著决定因素。

结论

25OHD缺乏在CKD儿童中普遍存在,并且与牛奶摄入、营养性维生素D补充剂使用和蛋白尿等潜在可改变的危险因素相关。25OHD缺乏是CKD儿童继发性甲状旁腺功能亢进和血清1,25(OH)2D降低的危险因素。